4.6 Article

Immunomodulatory Effects of Pentoxifylline: Profiling Data Based on RAW 264.7 Cellular Signaling

期刊

APPLIED SCIENCES-BASEL
卷 11, 期 17, 页码 -

出版社

MDPI
DOI: 10.3390/app11178273

关键词

Pentoxifylline (PTX); immunoprecipitation high-performance liquid chromatography (IP-HPLC); RAW 264; 7 cell; immunomodulation; osteoradionecrosis; COVID-19

资金

  1. Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2021R1I1A1A01058939]
  2. National Research Foundation of Korea [2021R1I1A1A01058939] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

The study showed that PTX plays an immunomodulatory role in RAW 264.7 cells by regulating various proteins, enhancing immunity and osteogenesis-related proteins, while decreasing proliferation, inflammation, and cellular apoptosis-related proteins expressions.
Pentoxifylline (PTX) is a methylxanthine derivative that has been developed as an immunomodulatory agent and an improvement of microcirculation. Osteoradionecrosis (ORN) is a serious complication of radiation therapy due to hypovascularity. Coronavirus disease 2019 (COVID-19) has spread globally. Symptoms for this disease include self-limiting respiratory tract illness to severe pneumonia and acute respiratory distress. In this study, the effects of PTX on RAW 264.7 cells were investigated to reveal the possibility of PTX as a therapeutic agent for ORN and COVID-19. To reveal PTX effects at the cellular level, protein expression profiles were analyzed in the PTX-treated RAW 264.7 cells by using immunoprecipitation high-performance liquid chromatography (IP-HPLC). PTX-treated RAW 264.7 cells showed increases in immunity- and osteogenesis-related proteins and concurrent decreases in proliferation-, matrix inflammation-, and cellular apoptosis-related proteins expressions. The IP-HPLC results indicate that PTX plays immunomodulatory roles in RAW 264.7 cells by regulating anti-inflammation-, proliferation-, immunity-, apoptosis-, and osteogenesis-related proteins. These results suggest that PTX may be used as supplement medications for ORN as well as for COVID-19.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据